Healthcare Realty Trust (HR) Financials

$15.17 +0.11 (+0.73%)

Closing price 03:59 PM Eastern

Extended Trading

$15.18 +0.01 (+0.03%)

As of 07:04 PM Eastern

Annual Income Statements for Healthcare Realty Trust

This table shows Healthcare Realty Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	33	46	64	213	30	72	67	41	-278	-654
Consolidated Net Income / (Loss)	34	47	66	218	31	72	67	41	-282	-664
Net Income / (Loss) Continuing Operations	34	47	66	218	31	72	67	41	-282	-664
Total Pre-Tax Income	33	47	65	216	29	72	67	41	-282	-664
Total Operating Income	94	111	161	151	146	79	82	-24	54	33
Total Gross Profit	280	317	614	696	481	303	323	589	843	795
Total Revenue	404	461	614	696	692	500	535	933	1,344	1,268
Operating Revenue	404	461	614	696	692	500	535	933	1,344	1,268
Total Cost of Revenue	123	144	0.00	0.00	211	197	212	344	500	473
Operating Cost of Revenue	123	144	0.00	-	211	197	212	344	500	473
Total Operating Expenses	187	206	453	545	334	224	241	612	789	761
Selling, General & Admin Expense	26	29	33	35	41	31	34	53	58	83
Depreciation Expense	154	177	245	280	290	190	203	453	731	675
Other Operating Expenses / (Income)	4.56	6.54	198	222	2.35	0.00	0.00	103	-1.95	0.00
Restructuring Charge	-	-	-	-	-	2.56	3.93	3.23	2.03	3.12
Total Other Income / (Expense), net	-60	-64	-97	65	-117	-7.22	-15	65	-336	-697
Interest Expense	58	65	97	102	118	78	53	149	259	243
Interest & Investment Income	-	-	-	-	-	-0.46	-0.80	-0.69	-1.68	-0.14
Other Income / (Expense), net	-2.20	1.63	0.03	166	0.84	71	39	214	-76	-455
Net Income / (Loss) Attributable to Noncontrolling Interest	0.63	1.43	1.66	4.16	0.60	0.00	0.00	-0.20	-3.82	-9.42
Basic Earnings per Share	$0.26	$0.34	$0.35	$1.04	$0.15	$0.52	$0.45	$0.15	($0.74)	($1.81)
Weighted Average Basic Shares Outstanding	126.07M	136.62M	181.06M	206.07M	205.72M	133.93M	142.64M	252.36M	378.93M	365.55M
Diluted Earnings per Share	$0.26	$0.33	$0.34	$1.02	$0.14	$0.52	$0.45	$0.15	($0.74)	($1.81)
Weighted Average Diluted Shares Outstanding	128.00M	140.26M	185.28M	210.06M	209.61M	134.01M	142.71M	253.87M	378.93M	365.55M
Weighted Average Basic & Diluted Shares Outstanding	-	141.72M	205.05M	205.06M	216.69M	218.75M	229.03M	380.78M	381.18M	350.82M
Cash Dividends to Common per Share	$1.17	$1.19	$1.21	$1.23	$1.25	$1.27	$1.21	$1.24	$1.24	$1.24

This table shows Healthcare Realty Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	28	-36	-87	-83	-68	-41	-311	-144	-93	-107
Consolidated Net Income / (Loss)	29	-36	-88	-84	-69	-42	-315	-146	-95	-108
Net Income / (Loss) Continuing Operations	29	-36	-88	-84	-69	-42	-315	-146	-95	-108
Total Pre-Tax Income	29	-36	-88	-84	-69	-42	-315	-146	-95	-108
Total Operating Income	-61	10	6.33	29	6.02	13	-238	11	11	250
Total Gross Profit	194	221	211	213	211	209	206	199	195	195
Total Revenue	306	338	333	338	342	330	327	316	315	310
Operating Revenue	306	338	333	338	342	330	327	316	315	310
Total Cost of Revenue	112	117	122	125	132	121	121	118	120	114
Operating Cost of Revenue	112	117	122	125	132	121	121	118	120	114
Total Operating Expenses	255	210	205	184	205	196	444	188	184	-54
Selling, General & Admin Expense	17	14	15	15	13	15	15	14	20	34
Depreciation Expense	158	185	184	183	183	180	178	173	163	160
Restructuring Charge	0.48	0.09	0.29	0.67	0.77	0.30	0.40	0.43	0.72	1.58
Total Other Income / (Expense), net	89	-47	-94	-113	-75	-54	-77	-157	-106	-358
Interest Expense	54	64	64	65	66	63	61	62	61	59
Interest & Investment Income	-0.12	0.09	-0.78	-0.02	-0.46	-0.43	-0.42	-0.15	0.21	0.23
Other Income / (Expense), net	144	17	-30	-47	-7.92	9.24	-16	-94	-45	-300
Net Income / (Loss) Attributable to Noncontrolling Interest	0.31	-0.52	-0.95	-0.97	-0.76	-1.14	-4.38	-2.16	-1.51	-1.37
Basic Earnings per Share	$0.08	($0.25)	($0.23)	($0.22)	($0.18)	($0.11)	($0.82)	($0.39)	($0.26)	($0.34)
Weighted Average Basic Shares Outstanding	328.81M	252.36M	378.84M	378.90M	378.93M	378.93M	379.45M	372.48M	358.96M	365.55M
Diluted Earnings per Share	$0.08	($0.25)	($0.23)	($0.22)	($0.18)	($0.11)	($0.82)	($0.39)	($0.26)	($0.34)
Weighted Average Diluted Shares Outstanding	332.03M	253.87M	378.84M	378.90M	378.93M	378.93M	379.45M	372.48M	358.96M	365.55M
Weighted Average Basic & Diluted Shares Outstanding	380.57M	380.78M	380.82M	380.86M	380.87M	381.18M	378.54M	363.03M	354.39M	350.82M
Cash Dividends to Common per Share	$0.31	-	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31

This table details how cash moves in and out of Healthcare Realty Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-2.25	-3.92	94	15	-96	15	-2.13	48	-35	43
Net Cash From Operating Activities	191	204	308	337	340	470	233	273	500	502
Net Cash From Continuing Operating Activities	191	204	308	337	340	470	233	273	500	502
Net Income / (Loss) Continuing Operations	34	47	66	218	31	72	67	41	-282	-664
Consolidated Net Income / (Loss)	34	47	66	218	31	72	67	41	-282	-664
Depreciation Expense	152	175	239	271	281	190	203	453	731	675
Amortization Expense	-	-	-	-	-	2.14	-0.51	4.57	13	21
Non-Cash Adjustments To Reconcile Net Income	9.63	2.87	-6.73	-147	33	206	-28	-193	110	495
Changes in Operating Assets and Liabilities, net	-3.70	-22	9.66	-5.02	-4.41	-0.85	-8.53	-33	-71	-26
Net Cash From Investing Activities	-274	-608	-2,455	176	-667	-555	-562	1,634	349	901
Net Cash From Continuing Investing Activities	-274	-608	-2,455	176	-667	-555	-562	1,634	349	901
Purchase of Property, Plant & Equipment	-309	-635	-2,448	-95	-645	-491	-467	-566	-280	-249
Acquisitions	0.00	0.00	-69	-	-	-66	-90	-100	-3.82	0.00
Purchase of Investments	-	-	-	-	0.00	0.00	-186	-1.00	-1.80	-0.51
Sale of Property, Plant & Equipment	35	27	81	-	0.00	4.90	184	1,203	701	1,226
Other Investing Activities, net	-0.20	0.00	-28	271	-23	-3.09	-4.03	1,099	-66	-76
Net Cash From Financing Activities	81	401	2,241	-499	231	100	328	-1,859	-884	-1,359
Net Cash From Continuing Financing Activities	81	401	2,241	-499	231	100	328	-1,859	-884	-1,359
Repayment of Debt	-367	-973	-762	-389	-1,334	-617	-25	-1,136	-405	-376
Repurchase of Common Equity	-1.67	-7.21	-3.41	-70	-12	-1.44	-3.80	-3.19	-2.30	-520
Payment of Dividends	-149	-163	-212	-258	-265	-163	-175	-285	-477	-463
Issuance of Debt	554	1,122	1,470	145	1,517	747	210	667	0.00	0.00
Issuance of Common Equity	44	422	1,747	73	325	142	331	23	0.13	0.10
Other Financing Activities, net	-0.24	0.92	2.42	-	0.00	-7.68	-9.18	-1,124	-0.02	-0.02
Cash Interest Paid	-	-	-	-	-	54	50	114	219	207

This table details how cash moves in and out of Healthcare Realty Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	23	3.38	-11	-14	-11	1.03	0.47	16	-16	43
Net Cash From Operating Activities	13	146	69	185	118	127	76	168	119	138
Net Cash From Continuing Operating Activities	13	146	69	185	118	127	76	168	119	138
Net Income / (Loss) Continuing Operations	29	-36	-88	-84	-69	-42	-315	-146	-95	-108
Consolidated Net Income / (Loss)	29	-36	-88	-84	-69	-42	-315	-146	-95	-108
Depreciation Expense	158	185	184	183	183	180	178	173	163	160
Amortization Expense	1.48	2.95	2.86	4.30	1.95	3.49	4.20	6.99	5.89	3.97
Non-Cash Adjustments To Reconcile Net Income	-134	-15	37	53	12	7.00	272	98	54	71
Changes in Operating Assets and Liabilities, net	-42	8.86	-67	28	-9.92	-22	-62	35	-9.23	11
Net Cash From Investing Activities	1,707	209	42	-48	119	237	-59	210	331	419
Net Cash From Continuing Investing Activities	1,707	209	42	-48	118	237	-59	210	331	419
Purchase of Property, Plant & Equipment	-142	-91	-91	-42	-72	-75	-50	-67	-69	-62
Purchase of Investments	-	-1.00	-0.30	-0.48	0.47	-1.49	0.00	-	-0.02	-0.49
Sale of Property, Plant & Equipment	763	331	150	11	206	335	0.50	304	420	502
Other Investing Activities, net	1,136	-30	-13	-16	-17	-21	-8.69	-26	-20	-21
Net Cash From Financing Activities	-1,696	-351	-122	-151	-248	-363	-17	-363	-466	-514
Net Cash From Continuing Financing Activities	-1,696	-351	-122	-151	-248	-363	-17	-363	-466	-514
Repayment of Debt	-65	-1,051	-0.67	-32	20	-392	-17	149	-407	-100
Repurchase of Common Equity	-0.04	-2.30	-1.73	-0.11	0.01	-0.46	-0.32	-273	-151	-96
Payment of Dividends	-1,196	1,004	-119	-119	-119	-119	-119	-119	-114	-112
Issuance of Debt	-435	821	0.00	-	-	149	120	-	-	-206
Other Financing Activities, net	0.05	-1,124	-0.10	0.06	0.03	-0.01	-0.11	0.08	0.02	-0.00
Cash Interest Paid	57	30	76	33	79	32	74	31	75	26

This table presents Healthcare Realty Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	3,172	3,748	6,450	6,188	6,791	4,259	13,850	12,637	10,651
Total Current Assets	13	11	100	126	119	13	61	26	69
Cash & Equivalents	13	11	100	126	115	13	61	26	69
Plant, Property, & Equipment, net	2,529	3,035	5,294	5,061	5,482	3,403	11,222	10,153	8,409
Plant, Property & Equipment, gross	3,205	3,853	6,316	6,269	7,184	4,741	12,868	12,380	10,892
Accumulated Depreciation	676	818	1,022	1,208	1,703	1,339	1,645	2,227	2,484
Total Noncurrent Assets	631	701	1,055	1,001	1,190	812	2,446	2,335	2,096
Long-Term Investments	-	0.00	69	67	64	162	327	312	473
Noncurrent Note & Lease Receivables	-	-	-	-	-	187	-	-	124
Goodwill	-	-	-	-	-	3.49	223	251	0.00
Intangible Assets	473	514	746	699	639	120	960	836	665
Other Noncurrent Operating Assets	158	187	240	236	487	339	936	937	834
Total Liabilities & Shareholders' Equity	3,172	3,748	6,450	6,188	6,791	4,259	13,850	12,637	10,651
Total Liabilities	1,761	1,963	3,079	2,847	3,556	2,074	6,168	5,714	5,345
Total Current Liabilities	95	105	168	185	200	86	244	212	223
Accounts Payable	95	105	168	185	200	86	244	212	223
Total Noncurrent Liabilities	1,666	1,858	2,912	2,662	3,355	1,956	5,924	5,502	5,045
Long-Term Debt	1,591	1,769	2,781	2,541	3,027	1,801	5,352	4,995	4,663
Capital Lease Obligations	-	-	-	-	198	-9.03	-	230	-5.00
Other Noncurrent Operating Liabilities	75	39	69	61	130	164	572	277	386
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	0.29	0.44	0.30	1.28
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	4.44	4.65	6.74	6.54	0.00	0.00	2.01	3.87	4.78
Total Equity & Noncontrolling Interests	1,407	1,780	3,363	3,335	3,235	2,185	7,680	6,919	5,301
Total Preferred & Common Equity	1,379	1,687	3,279	3,256	3,174	2,185	7,571	6,823	5,235
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,379	1,687	3,279	3,256	3,174	2,185	7,571	6,823	5,235
Common Stock	2,330	2,756	4,511	4,528	4,919	3,974	9,591	9,606	9,122
Retained Earnings	-	-	-	-	-	-3,045	-	-	-4,260
Accumulated Other Comprehensive Income / (Loss)	-	0.00	0.27	0.31	-17	-9.98	2.14	-11	-1.17
Other Equity Adjustments	-951	-1,069	-1,232	-1,272	-1,728	1,266	-2,023	-2,773	374
Noncontrolling Interest	28	93	85	79	61	0.00	109	96	66

This table presents Healthcare Realty Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	14,195	13,569	13,394	13,104	12,281	11,804	11,245
Total Current Assets	177	171	36	25	26	42	23
Cash & Equivalents	58	50	36	25	26	42	23
Plant, Property, & Equipment, net	11,512	10,894	10,725	10,393	9,966	9,406	8,926
Plant, Property & Equipment, gross	12,981	12,704	12,709	12,487	12,340	11,834	11,405
Accumulated Depreciation	1,469	1,810	1,984	2,094	2,374	2,428	2,479
Total Noncurrent Assets	2,507	2,504	2,512	2,565	2,167	2,274	2,218
Long-Term Investments	328	328	327	325	310	375	417
Noncurrent Note & Lease Receivables	-	-	-	-	-	122	123
Goodwill	149	261	251	251	0.00	0.00	0.00
Intangible Assets	969	929	922	890	816	765	718
Other Noncurrent Operating Assets	1,061	986	1,012	1,098	1,040	1,012	959
Total Liabilities & Shareholders' Equity	14,195	13,569	13,394	13,104	12,281	11,804	11,245
Total Liabilities	6,356	6,102	6,108	5,995	5,774	5,829	5,645
Total Current Liabilities	231	155	196	205	163	198	205
Accounts Payable	231	155	196	205	163	196	197
Other Current Nonoperating Liabilities	-	-	-	-	-	1.81	7.92
Total Noncurrent Liabilities	6,125	5,947	5,912	5,790	5,611	5,550	5,362
Long-Term Debt	5,570	5,362	5,340	5,227	5,108	5,148	4,958
Capital Lease Obligations	-	-	-	-	-	-6.20	-5.84
Other Noncurrent Operating Liabilities	545	585	572	559	502	408	410
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	2.00	2.49	3.20	3.88	3.88	3.88
Total Equity & Noncontrolling Interests	7,839	7,465	7,283	7,106	6,503	5,971	5,595
Total Preferred & Common Equity	7,727	7,359	7,179	7,004	6,416	5,887	5,515
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7,727	7,359	7,179	7,004	6,416	5,887	5,515
Common Stock	9,590	9,595	9,599	9,601	9,613	9,344	9,202
Retained Earnings	-	-	-	-	-	-4,038	-4,150
Accumulated Other Comprehensive Income / (Loss)	5.52	-8.55	9.33	17	4.79	6.99	-17
Other Equity Adjustments	-1,869	-2,228	-2,429	-2,615	-3,202	574	481
Noncontrolling Interest	112	106	104	102	87	84	80

This table displays calculated financial ratios and metrics derived from Healthcare Realty Trust's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.70%	14.14%	33.21%	13.43%	-0.63%	-27.80%	7.04%	74.38%	44.08%	-5.62%
EBITDA Growth	11.76%	18.44%	39.17%	47.04%	-27.31%	-19.90%	-5.87%	100.79%	11.31%	-61.87%
EBIT Growth	13.88%	23.12%	43.52%	96.62%	-53.65%	2.16%	-19.79%	57.97%	-111.49%	-1,824.71%
NOPAT Growth	12.65%	18.49%	45.60%	-6.41%	-3.16%	-45.72%	2.94%	-129.15%	259.07%	-38.17%
Net Income Growth	-27.04%	41.09%	38.51%	231.86%	-85.87%	134.72%	-7.67%	-38.95%	-793.20%	-135.36%
EPS Growth	-29.73%	26.92%	3.03%	200.00%	-86.27%	271.43%	-13.46%	-66.67%	-593.33%	-144.59%
Operating Cash Flow Growth	13.41%	6.59%	50.98%	9.71%	0.89%	38.10%	-50.51%	17.25%	83.25%	0.36%
Free Cash Flow Firm Growth	88.69%	-1,783.77%	-414.43%	119.49%	1,058.21%	-207.04%	146.43%	-442.17%	110.01%	161.32%
Invested Capital Growth	4.08%	18.53%	68.86%	-4.90%	-87.83%	806.76%	-39.42%	229.40%	-6.69%	-19.38%
Revenue Q/Q Growth	1.78%	4.53%	9.20%	-0.21%	0.58%	-31.39%	31.33%	39.23%	-0.56%	-1.60%
EBITDA Q/Q Growth	8.25%	7.50%	15.69%	-5.12%	0.93%	-22.92%	29.12%	26.66%	-1.45%	-24.88%
EBIT Q/Q Growth	20.64%	12.41%	23.66%	-8.54%	-3.76%	-3.28%	0.08%	0.17%	-37.91%	-20.58%
NOPAT Q/Q Growth	1.32%	9.38%	27.97%	-56.57%	1,134.31%	-48.79%	87.04%	39.47%	4.26%	116.44%
Net Income Q/Q Growth	-24.49%	16.14%	67.04%	-11.35%	-17.60%	112.93%	-26.54%	-59.39%	-1.95%	-11.14%
EPS Q/Q Growth	-23.53%	13.79%	78.95%	-11.30%	-22.22%	246.67%	-30.77%	-75.41%	15.91%	-14.56%
Operating Cash Flow Q/Q Growth	7.59%	1.50%	8.30%	5.52%	1.60%	26.48%	-37.24%	44.29%	-3.62%	2.18%
Free Cash Flow Firm Q/Q Growth	74.76%	-5.30%	5.50%	-30.09%	8,888.74%	-7,816.55%	1,432.12%	-28.39%	-27.14%	42.39%
Invested Capital Q/Q Growth	0.13%	1.02%	-1.02%	-1.17%	-88.07%	4.17%	-39.27%	-3.90%	-1.53%	-6.88%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.44%	68.81%	100.00%	100.00%	69.44%	60.67%	60.31%	63.11%	62.76%	62.67%
EBITDA Margin	60.18%	62.44%	65.23%	84.57%	61.86%	68.63%	60.35%	69.49%	53.69%	21.69%
Operating Margin	23.17%	24.06%	26.30%	21.70%	21.14%	15.89%	15.29%	-2.55%	4.03%	2.64%
EBIT Margin	22.63%	24.41%	26.30%	45.59%	21.26%	30.09%	22.55%	20.42%	-1.63%	-33.20%
Profit (Net Income) Margin	8.31%	10.27%	10.68%	31.25%	4.44%	14.45%	12.46%	4.36%	-20.99%	-52.35%
Tax Burden Percent	100.46%	100.00%	101.21%	100.80%	106.52%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	36.55%	42.08%	40.13%	68.00%	19.62%	48.02%	55.28%	21.36%	1,289.29%	157.66%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	3.19%	3.40%	3.39%	2.59%	4.59%	2.28%	1.62%	-0.29%	0.31%	0.22%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.85%	-0.41%	-1.00%	5.27%	63.76%	-2.47%	0.97%	1.71%	-6.35%	-15.26%
Return on Net Nonoperating Assets (RNNOA)	-0.87%	-0.43%	-0.85%	3.90%	-3.68%	-0.11%	0.84%	1.12%	-4.18%	-11.08%
Return on Equity (ROE)	2.32%	2.96%	2.54%	6.49%	0.91%	2.17%	2.46%	0.82%	-3.86%	-10.86%
Cash Return on Invested Capital (CROIC)	-0.80%	-13.56%	-47.83%	7.61%	161.19%	-157.99%	50.72%	-107.14%	7.23%	21.68%
Operating Return on Assets (OROA)	2.95%	3.25%	3.17%	5.02%	2.29%	2.24%	2.18%	2.10%	-0.17%	-3.62%
Return on Assets (ROA)	1.08%	1.37%	1.29%	3.44%	0.48%	1.08%	1.21%	0.45%	-2.13%	-5.70%
Return on Common Equity (ROCE)	2.27%	2.84%	2.45%	6.31%	0.44%	1.03%	2.43%	0.82%	-3.81%	-10.71%
Return on Equity Simple (ROE_SIMPLE)	2.43%	2.81%	2.00%	6.68%	0.00%	2.27%	3.05%	0.54%	-4.13%	-12.68%
Net Operating Profit after Tax (NOPAT)	94	111	161	151	146	79	82	-24	38	23
NOPAT Margin	23.17%	24.06%	26.30%	21.70%	21.14%	15.89%	15.29%	-2.55%	2.82%	1.85%
Net Nonoperating Expense Percent (NNEP)	4.04%	3.81%	4.39%	-2.68%	-59.18%	4.75%	0.65%	-2.00%	6.66%	15.48%
Return On Investment Capital (ROIC_SIMPLE)	3.12%	3.12%	2.63%	2.57%	2.37%	1.23%	2.06%	-0.18%	0.31%	0.24%
Cost of Revenue to Revenue	30.56%	31.19%	0.00%	0.00%	30.56%	39.33%	39.69%	36.89%	37.24%	37.33%
SG&A Expenses to Revenue	6.33%	6.24%	5.44%	5.05%	5.98%	6.15%	6.39%	5.65%	4.35%	6.55%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	46.27%	44.76%	73.70%	78.30%	48.30%	44.77%	45.02%	65.67%	58.73%	60.03%
Earnings before Interest and Taxes (EBIT)	91	113	161	317	147	150	121	190	-22	-421
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	243	288	401	589	428	343	323	648	721	275
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.30	1.31	0.96	0.96	1.17	0.74	1.46	0.55	0.87	1.16
Price to Tangible Book Value (P/TBV)	1.98	1.88	1.24	1.23	1.44	0.93	1.55	0.65	1.03	1.33
Price to Revenue (P/Rev)	4.45	4.80	5.11	4.51	5.66	4.73	5.98	4.44	4.41	4.80
Price to Earnings (P/E)	54.62	48.17	49.07	14.71	129.89	32.75	47.95	101.23	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	32.13%	7.93%	7.45%
Earnings Yield	1.83%	2.08%	2.04%	6.80%	0.77%	3.05%	2.09%	0.99%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.14	1.15	0.98	0.98	9.59	0.87	1.27	0.74	0.93	1.09
Enterprise Value to Revenue (EV/Rev)	8.44	8.82	9.51	8.00	9.60	10.94	9.00	9.88	8.12	8.10
Enterprise Value to EBITDA (EV/EBITDA)	14.03	14.13	14.58	9.46	15.51	15.94	14.91	14.22	15.13	37.34
Enterprise Value to EBIT (EV/EBIT)	37.29	36.15	36.17	17.56	45.13	36.37	39.92	48.38	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	36.42	36.68	36.17	36.89	45.38	68.84	58.88	0.00	287.99	438.29
Enterprise Value to Operating Cash Flow (EV/OCF)	17.84	19.97	18.99	16.52	19.51	11.63	20.69	33.78	21.84	20.48
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	12.55	1.29	0.00	1.88	0.00	12.46	4.49
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.13	0.99	0.83	0.76	0.80	1.00	0.82	0.70	0.75	0.88
Long-Term Debt to Equity	1.13	0.99	0.83	0.76	0.80	1.00	0.82	0.70	0.75	0.88
Financial Leverage	1.03	1.04	0.85	0.74	-0.06	0.05	0.86	0.65	0.66	0.73
Leverage Ratio	2.15	2.16	1.98	1.88	1.89	2.01	2.04	1.84	1.81	1.90
Compound Leverage Factor	0.78	0.91	0.79	1.28	0.37	0.97	1.13	0.39	23.38	3.00
Debt to Total Capital	52.99%	49.77%	45.21%	43.20%	44.49%	49.93%	45.06%	41.06%	43.01%	46.75%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	52.99%	49.77%	45.21%	43.20%	44.49%	49.93%	45.06%	41.06%	43.01%	46.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.07%	2.75%	1.49%	1.45%	1.18%	0.94%	0.00%	0.85%	0.82%	0.71%
Common Equity to Total Capital	45.95%	47.48%	53.30%	55.35%	0.00%	49.13%	54.94%	58.09%	56.17%	52.54%
Debt to EBITDA	6.55	6.15	6.94	4.31	6.42	9.41	5.55	8.26	7.24	16.93
Net Debt to EBITDA	6.49	6.11	6.52	3.99	6.19	8.87	5.01	7.66	6.77	14.96
Long-Term Debt to EBITDA	6.55	6.15	6.94	4.31	6.42	9.41	5.55	8.26	7.24	16.93
Debt to NOPAT	17.00	15.95	17.23	16.82	18.79	40.61	21.92	-224.62	137.85	198.76
Net Debt to NOPAT	16.86	15.85	16.18	15.54	18.12	38.31	19.78	-208.33	128.95	175.63
Long-Term Debt to NOPAT	17.00	15.95	17.23	16.82	18.79	40.61	21.92	-224.62	137.85	198.76
Altman Z-Score	0.80	0.87	0.78	0.93	0.91	0.53	0.12	0.50	0.71	0.09
Noncontrolling Interest Sharing Ratio	2.25%	4.06%	3.67%	2.63%	51.92%	52.38%	1.12%	1.12%	1.44%	1.40%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.14	0.11	0.60	0.68	0.00	0.59	0.15	0.25	0.12	0.31
Quick Ratio	0.14	0.11	0.60	0.68	0.00	0.58	0.15	0.25	0.12	0.31
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-24	-443	-2,278	444	5,143	-5,505	2,556	-8,747	876	2,288
Operating Cash Flow to CapEx	69.75%	33.48%	12.99%	354.19%	52.79%	96.64%	82.37%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-0.41	-6.80	-23.56	4.37	43.49	-70.88	48.12	-58.67	3.39	9.43
Operating Cash Flow to Interest Expense	3.30	3.13	3.18	3.32	2.88	6.05	4.38	1.83	1.93	2.07
Operating Cash Flow Less CapEx to Interest Expense	-1.43	-6.21	-21.31	2.38	-2.57	-0.21	-0.94	6.10	3.56	6.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.13	0.13	0.12	0.11	0.11	0.07	0.10	0.10	0.10	0.11
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.16	0.17	0.15	0.13	0.00	0.00	0.12	0.13	0.13	0.14
Accounts Payable Turnover	1.26	1.44	0.00	0.00	1.19	1.06	1.48	2.08	2.19	2.18
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	289.86	253.87	0.00	0.00	307.88	345.52	246.29	175.13	166.30	167.49
Cash Conversion Cycle (CCC)	-289.86	-253.87	0.00	0.00	-307.88	-345.52	-246.29	-175.13	-166.30	-167.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,989	3,543	5,982	5,689	692	6,277	3,803	12,526	11,688	9,423
Invested Capital Turnover	0.14	0.14	0.13	0.12	0.22	0.14	0.11	0.11	0.11	0.12
Increase / (Decrease) in Invested Capital	117	554	2,440	-293	-4,997	5,585	-2,475	8,723	-838	-2,265
Enterprise Value (EV)	3,408	4,067	5,840	5,574	6,640	5,467	4,813	9,215	10,915	10,271
Market Capitalization	1,799	2,211	3,137	3,141	3,917	2,364	3,196	4,140	5,927	6,084
Book Value per Share	$10.86	$11.91	$16.00	$15.73	$0.00	$14.52	$9.89	$19.89	$17.91	$14.77
Tangible Book Value per Share	$7.14	$8.28	$12.36	$12.36	$0.00	$11.60	$9.33	$16.78	$15.06	$12.90
Total Capital	3,002	3,554	6,151	5,883	6,180	6,460	3,977	13,034	12,147	9,964
Total Debt	1,591	1,769	2,781	2,541	2,750	3,225	1,792	5,352	5,225	4,658
Total Long-Term Debt	1,591	1,769	2,781	2,541	2,750	3,225	1,792	5,352	5,225	4,658
Net Debt	1,578	1,758	2,612	2,348	2,651	3,042	1,617	4,964	4,887	4,116
Capital Expenditures (CapEx)	274	608	2,368	95	645	486	282	-637	-421	-977
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-95	-105	-168	-185	-33	-200	-86	-244	-212	-223
Debt-free Net Working Capital (DFNWC)	-82	-94	-67	-59	0.00	-82	-73	-183	-186	-154
Net Working Capital (NWC)	-82	-94	-67	-59	0.00	-82	-73	-183	-186	-154
Net Nonoperating Expense (NNE)	60	64	96	-67	116	7.22	15	-65	320	687
Net Nonoperating Obligations (NNO)	1,578	1,758	2,612	2,348	-2,738	3,042	1,617	4,844	4,765	4,117
Total Depreciation and Amortization (D&A)	152	175	239	271	281	193	202	458	743	696
Debt-free, Cash-free Net Working Capital to Revenue	-23.51%	-22.79%	-27.34%	-26.57%	-4.73%	-40.10%	-16.10%	-26.17%	-15.78%	-17.54%
Debt-free Net Working Capital to Revenue	-20.27%	-20.35%	-10.99%	-8.45%	0.00%	-16.33%	-13.64%	-19.63%	-13.86%	-12.11%
Net Working Capital to Revenue	-20.27%	-20.35%	-10.99%	-8.45%	0.00%	-16.33%	-13.64%	-19.63%	-13.86%	-12.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.52	$0.34	$0.35	$1.04	$0.15	$0.24	$0.45	$0.15	($0.74)	($1.81)
Adjusted Weighted Average Basic Shares Outstanding	254.15M	136.62M	181.06M	206.07M	205.72M	218.08M	219.44M	252.36M	378.93M	365.55M
Adjusted Diluted Earnings per Share	$0.52	$0.33	$0.34	$1.02	$0.14	$0.24	$0.44	$0.15	($0.74)	($1.81)
Adjusted Weighted Average Diluted Shares Outstanding	256.08M	140.26M	185.28M	210.06M	209.61M	221.67M	224.22M	253.87M	378.93M	365.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	141.72M	205.05M	205.06M	216.69M	218.75M	229.03M	380.78M	381.18M	350.82M
Normalized Net Operating Profit after Tax (NOPAT)	67	74	96	112	103	57	60	-14	39	26
Normalized NOPAT Margin	16.67%	15.95%	15.68%	16.08%	14.82%	11.49%	11.21%	-1.55%	2.93%	2.02%
Pre Tax Income Margin	8.27%	10.27%	10.55%	31.00%	4.17%	14.45%	12.46%	4.36%	-20.99%	-52.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.58	1.73	1.67	3.12	1.24	1.94	2.27	1.28	-0.08	-1.74
NOPAT to Interest Expense	1.61	1.70	1.67	1.49	1.24	1.02	1.54	-0.16	0.15	0.10
EBIT Less CapEx to Interest Expense	-3.15	-7.61	-22.82	2.19	-4.21	-4.33	-3.05	5.55	1.54	2.29
NOPAT Less CapEx to Interest Expense	-3.11	-7.63	-22.82	0.55	-4.21	-5.24	-3.78	4.11	1.78	4.12
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	442.61%	344.55%	323.89%	118.52%	861.16%	225.16%	263.21%	701.37%	-169.23%	-69.79%
Augmented Payout Ratio	447.58%	359.78%	329.09%	150.83%	900.75%	227.15%	268.92%	709.21%	-170.04%	-148.12%

This table displays calculated financial ratios and metrics derived from Healthcare Realty Trust's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	124.22%	349.14%	132.99%	132.68%	11.72%	-2.25%	-1.84%	-6.45%	-7.84%	-6.26%
EBITDA Growth	289.37%	171.22%	46.66%	117.17%	-24.51%	-4.91%	-143.61%	-42.56%	-26.23%	-44.34%
EBIT Growth	623.74%	1.15%	-140.82%	-183.60%	-102.30%	-21.51%	-977.97%	-353.52%	-1,688.77%	-327.58%
NOPAT Growth	-515.33%	245.64%	-65.75%	49.64%	106.92%	21.10%	-3,862.11%	-63.24%	84.84%	1,865.73%
Net Income Growth	1,485.09%	-256.14%	-308.58%	-1,465.84%	-339.74%	-14.87%	-257.89%	-74.30%	-37.80%	-159.65%
EPS Growth	500.00%	-219.05%	-182.14%	-650.00%	-325.00%	56.00%	-256.52%	-77.27%	-44.44%	-209.09%
Operating Cash Flow Growth	-80.60%	134.21%	58.07%	163.16%	842.59%	-12.85%	10.06%	-9.17%	0.95%	8.40%
Free Cash Flow Firm Growth	-2,993.01%	-452.93%	-2,356.12%	-470.88%	117.12%	109.71%	118.48%	117.82%	50.23%	188.15%
Invested Capital Growth	108.18%	229.40%	96.05%	203.81%	-8.94%	-6.69%	-10.39%	-11.86%	-14.74%	-19.38%
Revenue Q/Q Growth	110.80%	10.35%	-1.52%	1.57%	1.22%	-3.45%	-1.10%	-3.21%	-0.28%	-1.79%
EBITDA Q/Q Growth	211.37%	-10.88%	-24.20%	3.24%	8.23%	12.26%	-134.76%	235.99%	39.00%	-15.30%
EBIT Q/Q Growth	277.05%	-66.27%	-184.20%	21.94%	89.63%	1,251.15%	-1,256.48%	67.16%	59.09%	-46.46%
NOPAT Q/Q Growth	-547.21%	112.07%	-39.68%	359.66%	-79.32%	111.17%	-1,973.95%	104.49%	4.01%	2,145.69%
Net Income Q/Q Growth	366.82%	-226.78%	-142.77%	4.94%	18.06%	39.25%	-656.38%	53.70%	35.22%	-14.47%
EPS Q/Q Growth	100.00%	-412.50%	8.00%	4.35%	18.18%	38.89%	-645.45%	52.44%	33.33%	-30.77%
Operating Cash Flow Q/Q Growth	-82.18%	1,065.16%	-52.64%	167.57%	-36.16%	7.73%	-40.19%	120.81%	-29.05%	15.68%
Free Cash Flow Firm Q/Q Growth	-411.95%	-27.53%	30.06%	-33.29%	114.40%	-27.62%	33.03%	28.52%	21.40%	38.83%
Invested Capital Q/Q Growth	226.14%	-3.90%	-0.60%	-2.48%	-2.25%	-1.53%	-4.53%	-4.09%	-5.44%	-6.88%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	63.29%	65.36%	63.34%	62.92%	61.54%	63.27%	62.95%	62.79%	61.88%	63.06%
EBITDA Margin	79.15%	63.92%	49.20%	50.01%	53.48%	62.18%	-21.86%	30.71%	42.81%	36.92%
Operating Margin	-19.87%	3.10%	1.90%	8.60%	1.76%	3.85%	-72.86%	3.38%	3.53%	80.63%
EBIT Margin	27.05%	8.27%	-7.07%	-5.43%	-0.56%	6.64%	-77.64%	-26.35%	-10.81%	-16.12%
Profit (Net Income) Margin	9.34%	-10.73%	-26.46%	-24.76%	-20.04%	-12.61%	-96.46%	-46.14%	-29.97%	-34.93%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	34.53%	-129.78%	374.18%	455.65%	3,599.37%	-189.94%	124.23%	175.12%	277.28%	216.71%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.38%	0.25%	0.16%	0.98%	0.13%	0.30%	-5.78%	0.27%	0.29%	6.78%
ROIC Less NNEP Spread (ROIC-NNEP)	0.79%	-1.10%	-2.14%	-2.14%	-1.33%	-0.75%	-8.86%	-2.93%	-1.92%	0.41%
Return on Net Nonoperating Assets (RNNOA)	0.59%	-0.72%	-1.60%	-1.51%	-0.89%	-0.50%	-6.11%	-2.12%	-1.40%	0.30%
Return on Equity (ROE)	-0.79%	-0.47%	-1.44%	-0.53%	-0.75%	-0.20%	-11.89%	-1.84%	-1.11%	7.08%
Cash Return on Invested Capital (CROIC)	-70.61%	-107.14%	-65.11%	-101.07%	9.65%	7.23%	9.83%	11.33%	14.62%	21.68%
Operating Return on Assets (OROA)	1.73%	0.85%	-0.78%	-0.80%	-0.06%	0.67%	-8.04%	-2.75%	-1.14%	-1.76%
Return on Assets (ROA)	0.60%	-1.11%	-2.91%	-3.63%	-1.98%	-1.28%	-9.98%	-4.82%	-3.17%	-3.81%
Return on Common Equity (ROCE)	-0.78%	-0.47%	-1.42%	-0.52%	-0.74%	-0.19%	-11.72%	-1.82%	-1.09%	6.98%
Return on Equity Simple (ROE_SIMPLE)	1.30%	0.00%	-1.22%	-2.50%	-3.95%	0.00%	-7.94%	-9.71%	-10.83%	0.00%
Net Operating Profit after Tax (NOPAT)	-61	7.34	4.43	20	4.21	8.89	-167	7.49	7.79	175
NOPAT Margin	-19.87%	2.17%	1.33%	6.02%	1.23%	2.69%	-51.00%	2.37%	2.47%	56.44%
Net Nonoperating Expense Percent (NNEP)	-2.17%	1.35%	2.30%	3.12%	1.46%	1.05%	3.08%	3.20%	2.21%	6.37%
Return On Investment Capital (ROIC_SIMPLE)	-0.45%	0.06%	0.03%	0.16%	0.03%	0.07%	-1.44%	0.07%	0.07%	1.76%
Cost of Revenue to Revenue	36.71%	34.64%	36.66%	37.08%	38.46%	36.73%	37.05%	37.21%	38.12%	36.94%
SG&A Expenses to Revenue	5.46%	4.26%	4.49%	4.57%	3.91%	4.42%	4.52%	4.43%	6.38%	11.04%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	83.15%	62.26%	61.44%	54.31%	59.78%	59.43%	135.81%	59.40%	58.36%	-17.57%
Earnings before Interest and Taxes (EBIT)	83	28	-24	-18	-1.91	22	-254	-83	-34	-50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	242	216	164	169	183	205	-71	97	135	114
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.75	0.55	0.86	0.87	0.73	0.87	0.78	0.99	1.14	1.16
Price to Tangible Book Value (P/TBV)	0.87	0.65	1.02	1.04	0.88	1.03	0.89	1.14	1.31	1.33
Price to Revenue (P/Rev)	8.61	4.44	5.61	4.74	3.80	4.41	3.73	4.42	4.88	4.80
Price to Earnings (P/E)	57.55	101.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	28.36%	32.13%	33.39%	35.58%	9.14%	7.93%	11.79%	7.94%	7.08%	7.45%
Earnings Yield	1.74%	0.99%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.85	0.74	0.91	0.93	0.85	0.93	0.88	0.99	1.08	1.09
Enterprise Value to Revenue (EV/Rev)	16.52	9.88	10.14	8.61	7.49	8.12	7.36	8.08	8.44	8.10
Enterprise Value to EBITDA (EV/EBITDA)	21.63	14.22	16.26	14.31	13.83	15.13	20.26	25.67	29.72	37.34
Enterprise Value to EBIT (EV/EBIT)	58.20	48.38	104.22	164.31	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	278.49	287.99	0.00	0.00	0.00	438.29
Enterprise Value to Operating Cash Flow (EV/OCF)	58.54	33.78	38.19	27.42	19.52	21.84	19.44	21.71	22.17	20.48
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	8.42	12.46	8.49	8.22	6.77	4.49
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.71	0.70	0.72	0.73	0.74	0.75	0.79	0.86	0.88	0.88
Long-Term Debt to Equity	0.71	0.70	0.72	0.73	0.74	0.75	0.79	0.86	0.88	0.88
Financial Leverage	0.75	0.65	0.75	0.71	0.67	0.66	0.69	0.72	0.73	0.73
Leverage Ratio	1.90	1.84	1.89	1.90	1.83	1.81	1.85	1.90	1.92	1.90
Compound Leverage Factor	0.66	-2.38	7.09	8.64	65.74	-3.44	2.30	3.33	5.31	4.13
Debt to Total Capital	41.54%	41.06%	41.80%	42.30%	42.37%	43.01%	43.98%	46.25%	46.93%	46.75%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	41.54%	41.06%	41.80%	42.30%	42.37%	43.01%	43.98%	46.25%	46.93%	46.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.83%	0.85%	0.84%	0.84%	0.85%	0.82%	0.78%	0.79%	0.80%	0.71%
Common Equity to Total Capital	57.63%	58.09%	57.36%	56.86%	56.77%	56.17%	55.24%	52.96%	52.27%	52.54%
Debt to EBITDA	10.89	8.26	7.66	6.75	7.14	7.24	10.51	12.41	13.52	16.93
Net Debt to EBITDA	10.13	7.66	7.12	6.29	6.66	6.77	9.82	11.41	12.32	14.96
Long-Term Debt to EBITDA	10.89	8.26	7.66	6.75	7.14	7.24	10.51	12.41	13.52	16.93
Debt to NOPAT	-141.51	-224.62	-251.70	-510.37	143.80	137.85	-38.35	-35.20	-34.75	198.76
Net Debt to NOPAT	-131.72	-208.33	-233.97	-475.66	134.17	128.95	-35.83	-32.35	-31.66	175.63
Long-Term Debt to NOPAT	-141.51	-224.62	-251.70	-510.37	143.80	137.85	-38.35	-35.20	-34.75	198.76
Altman Z-Score	0.61	0.46	0.70	0.69	0.60	0.72	0.55	0.19	0.24	0.21
Noncontrolling Interest Sharing Ratio	1.86%	1.12%	1.78%	1.13%	1.45%	1.44%	1.43%	1.46%	1.49%	1.40%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.76	0.25	1.10	0.18	0.12	0.12	0.16	0.21	0.11	0.31
Quick Ratio	0.76	0.25	1.10	0.18	0.12	0.12	0.16	0.21	0.11	0.31
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-6,834	-8,716	-6,096	-8,125	1,170	847	1,126	1,448	1,757	2,440
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	595.91%	0.00%	0.00%	152.66%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-126.24	-135.50	-95.60	-124.36	17.66	13.40	18.45	23.18	28.98	41.70
Operating Cash Flow to Interest Expense	0.23	2.27	1.09	2.83	1.78	2.01	1.25	2.69	1.97	2.36
Operating Cash Flow Less CapEx to Interest Expense	11.71	6.00	2.00	2.36	3.81	6.12	0.43	6.47	7.75	9.88
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.06	0.10	0.11	0.15	0.10	0.10	0.10	0.10	0.11	0.11
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.08	0.13	0.14	0.18	0.12	0.13	0.13	0.13	0.13	0.14
Accounts Payable Turnover	1.33	2.08	2.60	3.40	2.28	2.19	3.14	2.51	2.39	2.18
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	273.83	175.13	140.63	107.26	160.36	166.30	116.33	145.48	152.86	167.49
Cash Conversion Cycle (CCC)	-273.83	-175.13	-140.63	-107.26	-160.36	-166.30	-116.33	-145.48	-152.86	-167.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	13,034	12,526	12,451	12,142	11,869	11,688	11,158	10,702	10,119	9,423
Invested Capital Turnover	0.07	0.11	0.12	0.16	0.11	0.11	0.11	0.12	0.12	0.12
Increase / (Decrease) in Invested Capital	6,773	8,723	6,100	8,145	-1,166	-838	-1,293	-1,440	-1,750	-2,265
Enterprise Value (EV)	11,067	9,215	11,388	11,324	10,123	10,915	9,851	10,633	10,882	10,271
Market Capitalization	5,770	4,140	6,296	6,240	5,141	5,927	4,988	5,820	6,286	6,084
Book Value per Share	$20.31	$19.89	$19.33	$18.85	$18.39	$17.91	$16.83	$15.55	$15.19	$14.77
Tangible Book Value per Share	$17.37	$16.78	$16.20	$15.77	$15.39	$15.06	$14.69	$13.53	$13.21	$12.90
Total Capital	13,409	13,034	12,829	12,626	12,336	12,147	11,615	11,117	10,551	9,964
Total Debt	5,570	5,352	5,362	5,340	5,227	5,225	5,108	5,142	4,952	4,658
Total Long-Term Debt	5,570	5,352	5,362	5,340	5,227	5,225	5,108	5,142	4,952	4,658
Net Debt	5,185	4,964	4,984	4,977	4,877	4,887	4,772	4,725	4,512	4,116
Capital Expenditures (CapEx)	-621	-240	-59	31	-134	-259	50	-236	-351	-440
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-112	-244	-35	-196	-205	-212	-163	-198	-205	-223
Debt-free Net Working Capital (DFNWC)	-55	-183	15	-160	-180	-186	-137	-156	-183	-154
Net Working Capital (NWC)	-55	-183	15	-160	-180	-186	-137	-156	-183	-154
Net Nonoperating Expense (NNE)	-89	44	93	104	73	51	149	153	102	283
Net Nonoperating Obligations (NNO)	5,195	4,844	4,984	4,856	4,760	4,765	4,651	4,727	4,520	4,117
Total Depreciation and Amortization (D&A)	160	188	187	187	185	184	182	180	169	164
Debt-free, Cash-free Net Working Capital to Revenue	-16.74%	-26.17%	-3.07%	-14.91%	-15.17%	-15.78%	-12.20%	-15.02%	-15.93%	-17.54%
Debt-free Net Working Capital to Revenue	-8.14%	-19.63%	1.37%	-12.18%	-13.34%	-13.86%	-10.24%	-11.85%	-14.16%	-12.11%
Net Working Capital to Revenue	-8.14%	-19.63%	1.37%	-12.18%	-13.34%	-13.86%	-10.24%	-11.85%	-14.16%	-12.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.08	($0.25)	($0.23)	($0.22)	($0.18)	($0.11)	($0.82)	($0.39)	($0.26)	($0.34)
Adjusted Weighted Average Basic Shares Outstanding	328.81M	252.36M	378.84M	378.90M	378.93M	378.93M	379.45M	372.48M	358.96M	365.55M
Adjusted Diluted Earnings per Share	$0.08	($0.25)	($0.23)	($0.22)	($0.18)	($0.11)	($0.82)	($0.39)	($0.26)	($0.34)
Adjusted Weighted Average Diluted Shares Outstanding	332.03M	253.87M	378.84M	378.90M	378.93M	378.93M	379.45M	372.48M	358.96M	365.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	380.57M	380.78M	380.82M	380.86M	380.87M	381.18M	378.54M	363.03M	354.39M	350.82M
Normalized Net Operating Profit after Tax (NOPAT)	-42	7.41	4.63	21	4.75	9.10	8.97	7.79	8.29	176
Normalized NOPAT Margin	-13.80%	2.19%	1.39%	6.16%	1.39%	2.76%	2.75%	2.46%	2.63%	56.80%
Pre Tax Income Margin	9.34%	-10.73%	-26.46%	-24.76%	-20.04%	-12.61%	-96.46%	-46.14%	-29.97%	-34.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.53	0.43	-0.37	-0.28	-0.03	0.35	-4.16	-1.33	-0.56	-0.85
NOPAT to Interest Expense	-1.12	0.11	0.07	0.31	0.06	0.14	-2.73	0.12	0.13	2.99
EBIT Less CapEx to Interest Expense	13.01	4.17	0.55	-0.76	2.00	4.45	-4.97	2.45	5.22	6.67
NOPAT Less CapEx to Interest Expense	10.35	3.85	0.99	-0.16	2.09	4.25	-3.55	3.90	5.91	10.51
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1,331.67%	701.37%	-399.46%	-239.76%	233.62%	-169.23%	-93.77%	-83.43%	-78.85%	-69.79%
Augmented Payout Ratio	1,334.35%	709.21%	-404.00%	-242.09%	232.13%	-170.04%	-93.95%	-131.35%	-149.91%	-148.12%

Frequently Asked Questions About Healthcare Realty Trust's Financials

When does Healthcare Realty Trust's fiscal year end?

According to the most recent income statement we have on file, Healthcare Realty Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Healthcare Realty Trust's net income changed over the last 9 years?

Healthcare Realty Trust's net income appears to be on an upward trend, with a most recent value of -$663.90 million in 2024, falling from $33.56 million in 2015. The previous period was -$282.08 million in 2023. See Healthcare Realty Trust's forecast for analyst expectations on what’s next for the company.

What is Healthcare Realty Trust's operating income?

Healthcare Realty Trust's total operating income in 2024 was $33.48 million, based on the following breakdown:

Total Gross Profit: $794.87 million
Total Operating Expenses: $761.40 million

How has Healthcare Realty Trust revenue changed over the last 9 years?

Over the last 9 years, Healthcare Realty Trust's total revenue changed from $403.82 million in 2015 to $1.27 billion in 2024, a change of 214.1%.

How much debt does Healthcare Realty Trust have?

Healthcare Realty Trust's total liabilities were at $5.35 billion at the end of 2024, a 6.5% decrease from 2023, and a 203.5% increase since 2015.

How much cash does Healthcare Realty Trust have?

In the past 8 years, Healthcare Realty Trust's cash and equivalents has ranged from $11.23 million in 2016 to $126.22 million in 2018, and is currently $68.92 million as of their latest financial filing in 2024.

How has Healthcare Realty Trust's book value per share changed over the last 9 years?

Over the last 9 years, Healthcare Realty Trust's book value per share changed from 10.86 in 2015 to 14.77 in 2024, a change of 36.0%.

Related Companies

This page (NYSE:HR) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Realty Trust (HR) Financials

Frequently Asked Questions About Healthcare Realty Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Realty Trust (HR) Financials

Annual Income Statements for Healthcare Realty Trust

Quarterly Income Statements for Healthcare Realty Trust

Annual Cash Flow Statements for Healthcare Realty Trust

Quarterly Cash Flow Statements for Healthcare Realty Trust

Annual Balance Sheets for Healthcare Realty Trust

Quarterly Balance Sheets for Healthcare Realty Trust

Annual Metrics and Ratios for Healthcare Realty Trust

Quarterly Metrics and Ratios for Healthcare Realty Trust

Frequently Asked Questions About Healthcare Realty Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools